Wells Fargo’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111K | Sell |
87,752
-47,128
| -35% | -$59.4K | ﹤0.01% | 4726 |
|
|
2025
Q1 | $123K | Buy |
134,880
+42,892
| +47% | +$39.2K | ﹤0.01% | 4545 |
|
|
2024
Q4 | $146K | Buy |
91,988
+48,759
| +113% | +$77.5K | ﹤0.01% | 4494 |
|
|
2024
Q3 | $84.7K | Buy |
43,229
+1,622
| +4% | +$3.18K | ﹤0.01% | 4719 |
|
|
2024
Q2 | $68.2K | Buy |
41,607
+6,306
| +18% | +$10.3K | ﹤0.01% | 4794 |
|
|
2024
Q1 | $181K | Buy |
35,301
+8,374
| +31% | +$43K | ﹤0.01% | 4170 |
|
|
2023
Q4 | $154K | Sell |
26,927
-85,483
| -76% | -$490K | ﹤0.01% | 4238 |
|
|
2023
Q3 | $537K | Buy |
112,410
+89,054
| +381% | +$426K | ﹤0.01% | 3462 |
|
|
2023
Q2 | $99.3K | Sell |
23,356
-27,210
| -54% | -$116K | ﹤0.01% | 4776 |
|
|
2023
Q1 | $269K | Buy |
50,566
+48,866
| +2,874% | +$259K | ﹤0.01% | 4003 |
|
|
2022
Q4 | $10.7K | Sell |
1,700
-1,061
| -38% | -$6.66K | ﹤0.01% | 5204 |
|
|
2022
Q3 | $29K | Buy |
2,761
+498
| +22% | +$5.23K | ﹤0.01% | 4890 |
|
|
2022
Q2 | $13K | Sell |
2,263
-12,349
| -85% | -$70.9K | ﹤0.01% | 5341 |
|
|
2022
Q1 | $134K | Sell |
14,612
-11,448
| -44% | -$105K | ﹤0.01% | 4874 |
|
|
2021
Q4 | $394K | Buy |
26,060
+24,758
| +1,902% | +$374K | ﹤0.01% | 4525 |
|
|
2021
Q3 | $31K | Buy |
+1,302
| New | +$31K | ﹤0.01% | 5489 |
|